Flubrotizolam (FANAX) Pellets (0.5mg)

Flubrotizolam (FANAX) Pellets are a research chemical product designed for laboratory and analytical purposes. Each pellet contains a precisely measured dose of 0.5mg of Flubrotizolam, a novel and potent thienotriazolodiazepine derivative known for its high binding affinity to GABA-A receptor subtypes. These pellets are intended to provide researchers with a standardized method to study the pharmacological effects, receptor interactions, and potential applications of this compound.

Chemical Profile

Flubrotizolam is a synthetic chemical belonging to the benzodiazepine analog family, specifically a thienotriazolodiazepine. Its molecular formula is C15H10BrClFN3S, with a molar mass of 414.68 g/mol. This compound features functional groups that make it a compelling subject of study in understanding the mechanisms of GABAergic neurotransmission. The inclusion of bromine, chlorine, and fluorine atoms in its structure gives it pharmacokinetic attributes that distinguish it from other benzodiazepine-related compounds.

Features and Benefits

• Accurate Dosing

Each pellet is meticulously formulated to contain 0.5mg of Flubrotizolam, ensuring consistent and reproducible results in experimental settings. This precise concentration minimizes variability in research outcomes, providing a reliable basis for data analysis.

• High Purity

The Flubrotizolam used in these pellets is synthesized under strict quality control standards to ensure a purity level exceeding 99%. These stringent manufacturing processes reduce the likelihood of contamination or impurities affecting experimental results.

• Solid Form Stability

The pelletized form of Flubrotizolam enhances its stability and longevity compared to liquid solutions. This makes storage and handling more convenient, reducing the risk of degradation under typical laboratory conditions.

• Custom Tailored for Research

FANAX Pellets are specifically manufactured for scientific study and are not intended for human or animal consumption. This makes them a focused tool for professionals conducting advanced pharmacological and toxicological research.

Applications in Research

Flubrotizolam is predominantly studied for its effects as a potent central nervous system depressant. By binding to specific GABA-A receptor sites, the compound interacts with the inhibitory neurotransmitter GABA, exerting notable sedative, hypnotic, anxiolytic, and amnesic effects in experimental models. These attributes make it a candidate for the study of:

• GABAergic Activity

Researchers can investigate how Flubrotizolam modulates the activity and sensitivity of the GABA-A receptor, contributing to a better understanding of neurotransmitter-inhibitory balance in the central nervous system.

• Structure-Activity Relationships (SARs)

Flubrotizolam’s structural uniqueness offers valuable insights into the relationship between chemical modifications of benzodiazepine analogs and their pharmacodynamic profiles.

• Potential Therapeutic Mechanisms

Preliminary studies may explore its possible applications in the development of medications targeting sleep disorders, anxiety, or other neurological conditions.

Safety and Handling

It is critical to adhere to standardized laboratory safety protocols while handling Flubrotizolam (FANAX) Pellets. A Material Safety Data Sheet (MSDS) specific to this substance should be reviewed before use to assess potential hazards. Protective gear, including gloves and eye protection, is recommended to ensure safe handling, and the product should only be handled by trained professionals in a controlled environment. The pellets must be stored in a cool, dry place away from direct sunlight and moisture to maintain their integrity and efficacy.

Regulatory Compliance

Flubrotizolam is classified as a research chemical and may be subject to restrictions and regulations in certain jurisdictions. Researchers should confirm the legal status of this compound in their respective locations prior to ordering or using the product. Furthermore, FANAX Pellets are strictly sold under terms indicating that it is meant for laboratory research purposes only and not for clinical, veterinary, or household use.

Packaging and Availability

The pellets are securely sealed in tamper-evident containers to preserve quality during transport and storage. Batch information and expiration dates are clearly labeled to assist with recordkeeping and compliance.

Disclaimer

FANAX Pellets are intended solely for laboratory research and must not be used for any purpose other than those explicitly stated. Misuse of this product may result in legal consequences and risks to health and safety. It is the sole responsibility of the buyer to ensure compliance with all applicable regulations and guidelines.

By providing a rigorously controlled and standardized product, Flubrotizolam (FANAX) Pellets support researchers in advancing scientific knowledge in neuropharmacology and related fields. With their precision, high quality, and ease of use, these pellets represent a valuable tool for experimental work in understanding GABAergic systems and the properties of novel benzodiazepine analogs.